SCHEMBL954513

SCHEMBL954513

Cc1cccc(C(c2cccc(C)n2)c2cccc(C)n2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.52
CCR8 P51685 1/20 0.52
RECQL P46063 2/20 0.50
HTT P42858 1/20 0.50
NOS3 P29474 1/20 0.48
NOS2 P35228 1/20 0.48
RAB9A P51151 5/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 3/20 0.38
GRM5 P41594 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HDAC6 Q9UBN7 2/20 0.38
KDM4E B2RXH2 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
PKM P14618 2/20 0.38
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL959699 0.93 CCR1 (0.46) CCR1CCR8RECQLHTTNOS3
SCHEMBL5343791 0.87 NOS2 (0.42) CCR1CCR8RECQLHTTNOS3
SCHEMBL102150 0.82 CCR1 (0.50) CCR1CCR8RECQLHTTNOS3
SCHEMBL14577729 0.80 CCR1 (0.48) CCR1CCR8RECQLHTTNOS3
SCHEMBL2019306 0.80 CCR1 (0.48) CCR1CCR8RECQLHTTNOS3
SCHEMBL24375836 0.80 HTT (0.43) CCR1CCR8RECQLHTTNOS3
SCHEMBL17881711 0.80 HTT (0.43) CCR1CCR8RECQLHTTNOS3
SCHEMBL24375611 0.80 HTT (0.43) CCR1CCR8RECQLHTTNOS3
SCHEMBL12915375 0.80 HTT (0.40) CCR1CCR8RECQLHTTNOS3
SCHEMBL24375835 0.78 CCR1 (0.46) CCR1CCR8RECQLHTTNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390486-B1 OXIDATIVELY CURABLE COATING COMPOSITION MILLIKEN INDUSTRIALS LTD (GB) 2023-05-03 EP disclosed
CN-108431079-B Coating composition curable by oxidation 卡特克塞尔有限公司 2020-12-04 CN disclosed
US-10689540-B2 Oxidatively curable coating composition CATEXEL LIMITED (GB) 2020-06-23 US disclosed
EP-3390486-A1 OXIDATIVELY CURABLE COATING COMPOSITION Catexel Limited (GB) 2018-10-24 EP disclosed
US-20180298230-A1 OXIDATIVELY CURABLE COATING COMPOSITION CATEXEL LIMITED (GB) 2018-10-18 US disclosed
WO-2017103620-A1 OXIDATIVELY CURABLE COATING COMPOSITION CATEXEL LIMITED (GB) 2017-06-22 WO disclosed
EP-2371831-B1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO (JP) 2016-09-07 EP disclosed
US-9133098-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2015-09-15 US disclosed
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO., LTD. (JP) 2015-01-22 US disclosed
US-8871970-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2014-10-28 US disclosed
US-8617723-B2 Metal complexes MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-2371831-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND Nippon Soda Co., Ltd. (JP) 2011-10-05 EP disclosed
US-20110224457-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO., LTD. 2011-09-15 US disclosed
US-20110012100-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-01-20 US disclosed
US-7368516-B2 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst TOSOH CORPORATION (JP) 2008-05-06 US disclosed
US-20050187419-A1 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst TOSOH CORPORATION (JP) 2005-08-25 US disclosed
US-6900152-B2 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst TOSOH CORPORATION (JP) 2005-05-31 US disclosed
US-20020035029-A1 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst TOSOH CORPORATION (JP) 2002-03-21 US disclosed
US-6337297-B1 CHROMIUM CATALYST FOR TRIMERIZATION OF ETHYLENE WITH MULTIDENTATE LIGAND OR HALOGEN, CARBOXY GROUP TOSOH CORPORATION (JP) 2002-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187419-A1 Catalyst for trimerization of ethylene and process for trimerizing ethylene using the catalyst ACMSD, TAF9, ETV6 CCR1 1720/4885CCR8 1863/4885RECQL 4008/4885
US-20110224457-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND C9, TRPA1, PKD1 CCR1 2742/4885CCR8 2297/4885RECQL 4409/4885
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND C9, TRPA1, PKD1 CCR1 2742/4885CCR8 2297/4885RECQL 4409/4885
US-20110012100-A1 METAL COMPLEXES AP1M1, AP3M1, SOD1 CCR1 1608/4885CCR8 3259/4885RECQL 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.